Session Details
[LS2-B]luncheon (iBody)
Thu. Mar 5, 2026 12:15 PM - 1:15 PM JST
Thu. Mar 5, 2026 3:15 AM - 4:15 AM UTC
Thu. Mar 5, 2026 3:15 AM - 4:15 AM UTC
Conference Room 408/409(4th Floor)
[LS2-B-01]Marriage of single-cell and cell-free technologies for accelerating the development stage of antibody drugs
*Shoji Ohuchi1 (1. iBody Inc.)
[LS2-B-02]Influence of anti-drug antibody against therapeutic antibody in clinical practice
*Atsushi Yonezawa1 (1. Keio University)
